Literature DB >> 14701874

SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Gergana Dobreva1, Julia Dambacher, Rudolf Grosschedl.   

Abstract

Nuclear matrix attachment regions (MARs) are regulatory DNA sequences that are important for higher-order chromatin organization, long-range enhancer function, and extension of chromatin modifications. Here we characterize a novel cell type-specific MAR-binding protein, SATB2, which binds to the MARs of the endogenous immunoglobulin micro locus in pre-B cells and enhances gene expression. We found that SATB2 differs from the closely related thymocyte-specific protein SATB1 by modifications of two lysines with the small ubiquitive related modifier (SUMO), which are augmented specifically by the SUMO E3 ligase PIAS1. Mutations of the SUMO conjugation sites of SATB2 enhance its activation potential and association with endogenous MARs in vivo, whereas N-terminal fusions with SUMO1 or SUMO3 decrease SATB2-mediated gene activation. Sumoylation is also involved in targeting SATB2 to the nuclear periphery, raising the possibility that this reversible modification of a MAR-binding protein may contribute to the modulation of subnuclear DNA localization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14701874      PMCID: PMC305257          DOI: 10.1101/gad.1153003

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  71 in total

1.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

Review 2.  A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.

Authors:  P K Jackson
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

3.  Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development.

Authors:  Steven T Kosak; Jane A Skok; Kay L Medina; Roy Riblet; Michelle M Le Beau; Amanda G Fisher; Harinder Singh
Journal:  Science       Date:  2002-04-05       Impact factor: 47.728

4.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.

Authors:  Darja Schmidt; Stefan Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 6.  Nuclear neighbours: the spatial and functional organization of genes and nuclear domains.

Authors:  W Schul; L de Jong; R van Driel
Journal:  J Cell Biochem       Date:  1998-08-01       Impact factor: 4.429

7.  The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Authors:  Andrea Pichler; Andreas Gast; Jacob S Seeler; Anne Dejean; Frauke Melchior
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

8.  Inhibition of Stat1-mediated gene activation by PIAS1.

Authors:  B Liu; J Liao; X Rao; S A Kushner; C D Chung; D D Chang; K Shuai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator.

Authors:  Z Wang; A Goldstein; R T Zong; D Lin; E J Neufeld; R H Scheuermann; P W Tucker
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Nuclear domains.

Authors:  D L Spector
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  108 in total

Review 1.  The nucleoskeleton as a genome-associated dynamic 'network of networks'.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-10-05       Impact factor: 94.444

2.  The sympathetic neurotransmitter switch depends on the nuclear matrix protein Satb2.

Authors:  Galina Apostolova; Bernhard Loy; Roland Dorn; Georg Dechant
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

3.  SATB2 expression increased anchorage-independent growth and cell migration in human bronchial epithelial cells.

Authors:  Feng Wu; Ashley Jordan; Thomas Kluz; Steven Shen; Hong Sun; Laura A Cartularo; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2016-01-11       Impact factor: 4.219

4.  Performance of genomic bordering elements at predefined genomic loci.

Authors:  Sandra Goetze; Alexandra Baer; Silke Winkelmann; Kristina Nehlsen; Jost Seibler; Karin Maass; Jürgen Bode
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.

Authors:  Motomasa Ihara; Hideki Yamamoto; Akira Kikuchi
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Isolation and characterization of SATB2, a novel AT-rich DNA binding protein expressed in development- and cell-specific manner in the rat brain.

Authors:  Marianna Szemes; Andrea Gyorgy; Cloud Paweletz; Albert Dobi; Denes V Agoston
Journal:  Neurochem Res       Date:  2006-04-04       Impact factor: 3.996

7.  NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression.

Authors:  Adam Rosendorff; Shuhei Sakakibara; Sixin Lu; Elliott Kieff; Yan Xuan; Alessandra DiBacco; Yujiang Shi; Yang Shi; Grace Gill
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

8.  SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.

Authors:  Andrew M Bellizzi
Journal:  Histopathology       Date:  2019-11-15       Impact factor: 5.087

9.  Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs.

Authors:  Jin-Hai Ye; Yuan-Jin Xu; Jun Gao; Shi-Guo Yan; Jun Zhao; Qisheng Tu; Jin Zhang; Xue-Jing Duan; Cesar A Sommer; Gustavo Mostoslavsky; David L Kaplan; Yu-Nong Wu; Chen-Ping Zhang; Lin Wang; Jake Chen
Journal:  Biomaterials       Date:  2011-04-13       Impact factor: 12.479

10.  SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.

Authors:  Stephanie Hammerich-Hille; Benny A Kaipparettu; Anna Tsimelzon; Chad J Creighton; Shiming Jiang; Jose M Polo; Ari Melnick; Rene Meyer; Steffi Oesterreich
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.